Antibiotic Production Mechanisms in Actinomycetes

Actinomycetes, notably the genus Streptomyces, are prolific producers of clinically important antibiotics. These filamentous bacteria house biosynthetic gene clusters (BGCs) encoding modular enzymatic machines—such as polyketide synthases, nonribosomal peptide synthetases and ribosomally synthesised and post-translationally modified peptide pathways—that assemble complex secondary metabolites. Production is orchestrated by multilayered regulatory networks integrating nutrient sensing, morphological differentiation and small-molecule signals. The stringent response mediator (p)ppGpp and the second messenger cyclic di-GMP couple environmental cues to global transcriptional regulators, linking metabolic stress to activation of antibiotic biosynthesis. Many BGCs remain silent under laboratory conditions, demanding innovative activation strategies. Recent advances in genomics, metabolomics and synthetic biology have enabled heterologous expression, ribosome engineering and rational mutagenesis to unlock cryptic pathways, offering new opportunities for antibiotic discovery and yield optimisation.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Antibiotic Production Mechanisms in Actinomycetes publication trend

The graph below shows the total number of articles in antibiotic production mechanisms in actinomycetes across all publications each year (not limited to Nature Index journals).

Technical terms

Biosynthetic gene cluster (BGC): A contiguous set of genes encoding enzymes and regulatory proteins responsible for the synthesis of a specific natural product.

Secondary metabolite: A small organic compound not essential for growth but often involved in ecological interactions, including antibiotics.

Cyclic di-GMP (c-di-GMP): A bacterial second messenger that regulates processes such as morphological differentiation and secondary metabolism.

Stringent response ((p)ppGpp): A global stress response in bacteria mediated by guanosine tetra- and pentaphosphates that reprogrammes transcription under nutrient limitation.

Ribosome engineering: A strategy to induce mutations in ribosomal proteins or RNA polymerase to activate silent biosynthetic pathways and enhance metabolite yields.

Heterologous expression: The introduction and functional expression of a biosynthetic gene cluster in a non-native host to facilitate discovery or improve production.

References

1. CdgB Regulates Morphological Differentiation and Toyocamycin Production in Streptomyces diastatochromogenes 1628. International Journal of Molecular Sciences (2024).
2. Properties of Multidrug-Resistant Mutants Derived from Heterologous Expression Chassis Strain Streptomyces albidoflavus J1074. Microorganisms (2023).
3. Recent Advances in Strategies for Activation and Discovery/Characterization of Cryptic Biosynthetic Gene Clusters in Streptomyces. Microorganisms (2020).
4. The Application of Ribosome Engineering to Natural Product Discovery and Yield Improvement in Streptomyces. Antibiotics (2019).